1.9900
0.0000
(0.00%)
As of 8:11:46 AM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in HKD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 1 | 27 | 28 |
| Avg. Estimate | 7.56B | 7.94B | 32.97B | 34.26B |
| Low Estimate | 7.18B | 7.94B | 31.22B | 30.79B |
| High Estimate | 8.3B | 7.94B | 35.96B | 43.59B |
| Year Ago Sales | 8.24B | 9.69B | 34.17B | 32.97B |
| Sales Growth (year/est) | -8.33% | -18.05% | -3.51% | 3.89% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CVGU.F | -- | -- | -- | -- |
| S&P 500 | 9.90% | 11.00% | 14.01% | 13.54% |
Related Tickers
002422.SZ Sichuan Kelun Pharmaceutical Co., Ltd.
28.13
-0.04%
ON4.F Ono Pharmaceutical Co., Ltd.
9.90
0.00%
4536.T Santen Pharmaceutical Co., Ltd.
1,551.50
-0.26%
600436.SS PIENTZEHUANG
202.51
+0.75%
CUP0.MU Chugai Pharmaceutical Co., Ltd.
20.00
-0.99%
4151.T Kyowa Kirin Co., Ltd.
2,324.00
+0.43%
4578.T Otsuka Holdings Co., Ltd.
8,034.00
+0.35%
600276.SS HENGRUI PHARMA
44.65
+0.02%
ALPMY Astellas Pharma Inc.
9.74
+1.46%
NOV.F Novo Nordisk A/S
82.86
-1.71%